PDP1 and neoplasm: DCA and AZD7545 both prevented PDH phosphorylation in H460par and H460res cells, but activated AMPK, induced cell death and inhibited clonogenic growth only in H460res cells (Supplementary Fig. 4a, b), thereby validating PDH kinases as a therapeutic target in tumor cells with mTOR-mediated therapy resistance.